| Phase 4 |
| NCT07300956 |
Treating Young Children With Attention Deficit Hyperactivity Disorder |
Attention-Deficit/Hyperactivity Disorder (ADHD) |
Recruiting |
2026-09-14 |
| NCT04991389 |
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics |
Obstructive Sleep Apnea |
Recruiting |
2026-01-07 |
| NCT04995562 |
Use of Hyperpolarized 129Xe MR Lung Imaging in Infants |
Lungs; Developmental Disorder |
Recruiting |
2026-01-07 |
| NCT07177300 |
Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations… |
Sickle Cell Anemia (HbSS) |
Recruiting |
2025-09-16 |
| NCT05517655 |
BEGIN Novel ImagiNG Biomarkers |
Cystic Fibrosis |
Active, Not Recruiting |
2026-09-22 |
| NCT07770152 |
Semaglutide in Youth With Autism Spectrum Disorder |
Autism Spectrum Disorder |
Not Yet Recruiting |
2026-08-18 |
| NCT04219280 |
Evaluating Treatment of ADHD in Children With Down Syndrome |
Down Syndrome |
Active, Not Recruiting |
2026-08-10 |
| NCT04128995 |
Surgical or Medical Treatment |
Diabetes Mellitus, Type 2 |
Active, Not Recruiting |
2026-03-24 |
| NCT05659147 |
Imaging Biomarkers of Pancreatic Function and Disease |
Pancreatitis |
Enrolling by Invitation |
2026-03-18 |
| NCT04467957 |
Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis |
Cystic Fibrosis |
Active, Not Recruiting |
2026-01-28 |
| Phase 3 |
| NCT04216927 |
NO During CPB in Neonates to Reduce Risk of AKI |
AKI |
Recruiting |
2026-08-05 |
| NCT07146048 |
A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop |
Rheumatic Heart Disease |
Recruiting |
2026-06-22 |
| NCT07187206 |
Safety and Efficacy of FETO in CDH Phase III |
Congenital Diaphragmatic Hernia |
Recruiting |
2025-09-22 |
| NCT07798232 |
Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children |
Rheumatic Heart Disease in Children |
Not Yet Recruiting |
2026-09-03 |
| Phase 2/3 |
| NCT05660746 |
Precise Infliximab Exposure and Pharmacodynamic Control |
Crohn Disease |
Recruiting |
2026-05-05 |
| Phase 2 |
| NCT06153173 |
Mirdametinib in Histiocytic Disorders |
Langerhans Cell Histiocytosis (LCH) |
Recruiting |
2026-09-21 |
| NCT05538208 |
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study |
Lupus Nephritis |
Recruiting |
2026-09-14 |
| NCT02532452 |
Third Party Viral Specific T-cells (VSTs) |
Viral Infection |
Recruiting |
2026-09-04 |
| NCT04230356 |
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific… |
Allogeneic Stell Cell Transplant |
Recruiting |
2026-09-04 |
| NCT06450925 |
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation. |
Graft Vs Host Disease |
Recruiting |
2026-08-24 |
| NCT07635056 |
Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for… |
Neuroblastoma |
Recruiting |
2026-08-24 |
| NCT04925375 |
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung… |
Interstitial Lung Disease |
Recruiting |
2026-07-22 |
| NCT05501756 |
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation |
Allogeneic Hematopoietic Cell Transplantation |
Recruiting |
2026-06-12 |
| NCT05485155 |
Zemaira Eosinophilic Esophagitis Pilot Study |
Eosinophilic Esophagitis |
Recruiting |
2025-12-17 |
| NCT02143830 |
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy |
Fanconi Anemia |
Recruiting |
2025-11-12 |